3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Neuroendocrine Tumors
2
Vaginal Neoplasms
1
Lymphoma, Follicular
1
Glioblastoma
1
Endometrial Serous Adenocarcinoma
1
Astrocytoma
1
Interventions
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
5
Whole-Body Irradiation
4
Busulfan
4
Biopsy
4
venetoclax
3
Specimen Handling
3
Injections
3
Cytarabine
3
Azacitidine
3
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Stem Cell Transplantation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
CPX-351
2
treosulfan
1
peginterferon alfa-2b
1
olutasidenib
1
itacitinib
1
eltrombopag
1
canakinumab
1
aldesleukin
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
30 days
×
Clear all
No trials found.